Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Buprenorphine vs Morphine for Neonatal Abstinence Syndrome
NCT01452789Phase 3Completed
- Sponsor
- Thomas Jefferson University
- Start
- Nov 2011
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in neonatal abstinence syndrome (NAS) (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Length of Treatment. Started Nov 2011; status: completed.
02
Drugs
buprenorphine
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT01452789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452789.